Finance

Lists
Why is 600285 up 2.43%?
Dive Deeper
600285:SHA
Henan Lingrui Pharmaceutical Co., Ltd.
CNÂ¥24.00
+2.43%
(+0.57) 1D
Nov 17, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600285...
Open
CNÂ¥23.44
High
CNÂ¥24.16
Low
CNÂ¥23.31
Mkt. cap
13.29B
Avg. vol.
12.81M
Volume
16.40M
Dividend
4.58%
Quarterly dividend
CNÂ¥0.28
Ex-dividend date
Jun 11, 2026
P/E ratio
16.45
52-wk high
CNÂ¥24.16
52-wk low
CNÂ¥18.51
EPS
CNÂ¥1.46
Shares outstanding
586.45M
No. of employees
3K
Open
CNÂ¥23.44
High
CNÂ¥24.16
Low
CNÂ¥23.31
Mkt. cap
13.29B
Avg. vol.
12.81M
Volume
16.40M
Dividend
4.58%
Quarterly dividend
CNÂ¥0.28
Ex-dividend date
Jun 11, 2026
P/E ratio
16.45
52-wk high
CNÂ¥24.16
52-wk low
CNÂ¥18.51
EPS
CNÂ¥1.46
Shares outstanding
586.45M
No. of employees
3K
News stories
From web sources and news partners
About Henan Lingrui Pharmaceutical Co., Ltd.
CEO-
Employees2.79K
Founded1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
812.03M
1.13B
1.02B
991.98M
Cost of goods sold
194.87M
245.62M
207.96M
204.50M
Cost of revenue
194.87M
245.62M
207.96M
204.50M
Research and development expenses
64.52M
31.48M
21.18M
27.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
427.97M
563.59M
499.32M
513.20M
Operating expense
503.84M
613.11M
537.69M
554.90M
Total operating expenses
698.71M
858.73M
745.65M
759.40M
Operating income
113.32M
267.34M
276.25M
232.58M
Other non operating income
-1.78M
-111.14K
-323.41K
357.18K
EBT including unusual items
121.91M
285.51M
291.80M
262.08M
EBT excluding unusual items
125.02M
284.47M
287.74M
247.29M
Income tax expense
13.00M
38.07M
41.39M
36.55M
Effective tax rate
10.66%
13.33%
14.18%
13.95%
Other operating expenses
17.18M
9.49M
14.23M
9.13M
Net income
108.57M
246.33M
248.76M
223.71M
Net profit margin
13.37%
21.88%
24.34%
22.55%
Earnings per share
-
-
-
-
Interest and investment income
14.40M
18.00M
12.30M
15.12M
Interest expense
-908.91K
-763.97K
-499.14K
-758.23K
Net interest expenses
13.50M
17.24M
11.81M
14.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
137.12M
291.15M
299.03M
256.38M
Gain or loss from assets sale
-6.99M
-
15.10K
-15.10K
Upcoming events
AI content may include mistakes. Learn more
Google apps